Eledon Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.30 | -$0.30 | -$0.30 |
| Q2 2024 | 1 | -$0.32 | -$0.32 | -$0.32 |
| Q3 2024 | 3 | -$0.40 | -$0.16 | -$0.29 |
| Q1 2025 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q2 2025 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q3 2025 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q4 2025 | 1 | -$0.26 | -$0.26 | -$0.26 |
Eledon Pharmaceuticals, Inc. Earnings Date And Information
Eledon Pharmaceuticals, Inc. last posted its earnings results on Monday, August 19th, 2024. The company reported $-0.32 earnings per share for the quarter, missing analysts' consensus estimates of $-0.31 by $0.01. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Eledon Pharmaceuticals, Inc. has generated $0 earnings per share over the last year ($-1.64 diluted earnings per share) and currently has a price-to-earnings ratio of 16.68. Eledon Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based on prior year's report dates.
Eledon Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | $1.48 | $0 | $0 | ||
| 08/19/2024 | Q2 2024 | -$0.31 | -$1.06 | -0.75 | $0 | $0 |
| 08/19/2024 | Q1 2024 | -$0.31 | -$0.34 | -0.03 | $0 | |
| 08/19/2024 | Q4 2023 | -$0.31 | -$0.40 | -0.09 | $560,000 | |
| 11/09/2023 | Q3 2023 | -$0.41 | -$0.35 | 0.06 | $0 | |
| 08/10/2023 | Q2 2023 | -$0.47 | -$0.40 | 0.07 | $0 | |
| 05/11/2023 | Q1 2023 | -$0.71 | -$0.73 | -0.02 | $0 | |
| 03/30/2023 | Q4 2022 | -$0.70 | -$4.21 | -3.51 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.68 | -$0.73 | -0.05 | $0 | |
| 08/11/2022 | Q2 2022 | -$0.72 | -$0.65 | 0.07 | $0 | |
| 05/12/2022 | Q1 2022 | -$0.67 | -$0.69 | -0.02 | $0 | |
| 03/24/2022 | Q4 2021 | -$0.83 | -$0.62 | 0.21 | $120 | |
| 11/12/2021 | Q3 2021 | -$0.66 | $0 | |||
| 08/12/2021 | Q2 2021 | -$0.58 | -$0.50 | 0.08 | $0 | |
| 05/13/2021 | Q1 2021 | -$0.57 | $0 | |||
| 03/30/2021 | Q4 2020 | -$8.19 | $120,000 | |||
| 11/16/2020 | Q3 2020 | -$1.75 | -$5.51 | -3.76 | $120,000 | |
| 08/13/2020 | Q2 2020 | -$2.97 | -$2.74 | 0.23 | $0 | |
| 05/15/2020 | Q1 2020 | -$2.88 | -$8.52 | -5.64 | $0 | |
| 03/16/2020 | Q4 2019 | -$4.68 | -$5.75 | -1.07 | $0 |
Eledon Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Eledon Pharmaceuticals, Inc.'s earnings date?
Eledon Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates.
-
How can I listen to Eledon Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Eledon Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Eledon Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Eledon Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Eledon Pharmaceuticals, Inc. generate each year?
Eledon Pharmaceuticals, Inc. (:ELDN) has a recorded net income of $0. Eledon Pharmaceuticals, Inc. has generated $-0.0016 earnings per share over the last four quarters.
-
What is Eledon Pharmaceuticals, Inc.'s price-to-earnings ratio?
Eledon Pharmaceuticals, Inc. (:ELDN) has a price-to-earnings ratio of 16.68 and price/earnings-to-growth ratio is 0.2.
